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SUMMARY  
Setting 
Incidence rates of tuberculosis in South Africa are amongst the highest in the world, and 
drug-resistance is a major concern. Understanding geographic variation in disease may 
guide targeted interventions.  
Objective 
We aimed to characterise the spatial distribution of drug-resistant tuberculosis (DRTB) in a 
rural area of KwaZulu-Natal, South Africa, and test for clustering. 
Design 
This was a cross-sectional analysis of DRTB patients managed at a rural district hospital 
from 2011-2015. We mapped all patients in hospital data to local areas; and linked to a 
population-based demographic surveillance system to map patients to individual 
homesteads. We used kernel density estimation to visualise the distribution of disease and 
tested for clustering using spatial scan statistics. 
Results 
There were 489 patients with DRTB in the sub-district; 111 lived in the smaller demographic 
surveillance area. Spatial clustering analysis identified a high-risk cluster (relative risk of 
DRTB within cluster compared to outside: 3.0, p<0.001) in the south-east, a region 
characterised by high population density and high HIV prevalence.   
Conclusion 
We have demonstrated evidence of a geographic high risk cluster of DRTB. This suggests 
that targeting interventions to spatial areas of highest risk, where transmission may be 





Incidence rates of tuberculosis (TB) in South Africa are amongst the highest in the world.1 In 
2015 there were an estimated 454,000 new diagnoses, a rate of 834 per 100,000 
population, and it is the leading natural cause of death in the country.1, 2 Rates of TB are 
particularly high in the province of KwaZulu-Natal, largely driven by the high prevalence of 
human immunodeficiency virus (HIV) and complicated by TB drug resistance.3, 4 
Understanding the spatial distribution of disease is important for effective control. Spatial 
analyses can be used to identify the worst affected areas, generate hypotheses about 
transmission, and guide interventions.5 Tests of spatial clustering can be used to identify 
groups of patients that occur closer together in space than would be expected by chance. 
These analyses have been used to identify areas of likely TB transmission.6-14 Visualisation 
of spatial data on maps also provides a powerful means of communicating information about 
the disease to policy makers and the public.  
The Africa Health Research Institute (AHRI) in the Hlabisa sub-district of KwaZulu-Natal, 
South Africa, maintains a large health and demographic surveillance system. This includes 
individual residential locations mapped to an accuracy of less than two metres, and routine 
linkage to public sector records.15, 16 The aim of this study was to characterise the spatial 
distribution of drug-resistant TB (DRTB) in the sub-district, test for spatial clustering, and 
discuss implications for prevention and care.  
 
STUDY POPULATION AND METHODS 
Study area 
Hlabisa health sub-district is an area of approximately 1,450km2 and 247,350 residents in 
uMkhanyakude district, northern KwaZulu-Natal, South Africa (Figure 1A). It is characterised 
by high prevalence of HIV with high rates of associated TB (577 recorded TB cases per 
100,000 population in uMkhanyakude in 2015; 64.3% HIV positive).3, 17 The AHRI 
demographic surveillance area is located within the Hlabisa sub-district (Figure 1B). This a 
region of 435km2, with approximately 11,000 homesteads and 60,000 residents, in which 
AHRI has undertaken population-based demographic surveillance since 2000.15  
Data sources and identification of DRTB patients 
This was a cross-sectional analysis of patients diagnosed with DRTB between 2011 and 
2015 who were resident in the Hlabisa health sub-district. Since 2011, all patients with DRTB 
aged 12 years and older were admitted to the TB ward at Hlabisa hospital for at least the 
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first month of treatment. Since July 2013, individuals in the sub-district with DRTB have been 
identified through Xpert MTB/RIF testing at one of 17 primary health care clinics. Prior to 
that, most patients were identified through culture-based methods, apart from a small 
number of patients diagnosed using Xpert MTB/RIF tests at a clinical trial site.18  
We identified patients with DRTB using ICD-10 discharge codes in the Hlabisa hospital 
information system. We defined DRTB based on South African coding standards, 
incorporating codes for rifampicin mono-resistant, multidrug-resistant (MDR) and extensively 
drug-resistant (XDR) TB.19 We calculated the proportion of patients in the hospital 
admissions data who had DRTB, and described characteristics of patients. Data from the 
hospital information system are routinely linked to the AHRI demographic surveillance data 
using the South African identification number or through a standard probabilistic matching 
algorithm.15 We used linked data to identify individual homestead locations. 
The research was approved by the Biomedical Research Ethics Committee of the University 
of KwaZulu-Natal (ref. BE290/16), the Ethics Committee of the London School of Hygiene 
and Tropical Medicine (ref. 11814), and the Health Research Committee of the KwaZulu-
Natal Department of Health (ref. 378/16). These committees waived the requirement for 
individual informed consent to use the hospital admissions data, as the data were routinely 
collected from hospital records and there was no direct interaction with individual patients. 
Spatial analysis 
We conducted two spatial analyses which derived patient geographic locations using 
different methods: a local area analysis which covered the entire Hlabisa sub-district; and a 
micro-geographic analysis using the precise locations of patient homesteads within the 
smaller AHRI demographic surveillance area.  
In the local area analysis, we compared the spatial distribution of DRTB patients with all 
other hospital admissions. Local areas are informal regions used by local populations to 
describe the sub-district, and have been mapped by AHRI (315 local areas in the Hlabisa 
sub-district in total, Figure 1B). We extracted patient-reported local areas of residence from a 
free text field in the hospital data, and matched them to mapped names of local areas. 
In the micro-geographic analysis, we compared point residential locations for patients with 
DRTB to the spatial distribution of the general population. We used residential locations from 
the AHRI demographic surveillance data. For DRTB patients, we identified the exact 
homestead of residence which was recorded in the surveillance system closest in time to the 
patient’s date of admission to Hlabisa hospital. The distribution of the general population was 
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derived by calculating total person years of residence in each homestead over the study 
period.  
We tested for spatial clustering of DRTB in both the local area and micro-geographic 
analyses. We used spatial scan statistics, implemented in the SaTScan software,20 to test 
the hypothesis that DRTB patients were closer together in space than the underlying 
population distribution. Scan statistics are used to compare the observed number of cases 
within spatial windows of various sizes with those that would be expected, in this case, under 
a random Poisson distribution. A likelihood ratio is calculated for each window which 
compares the observed and expected numbers of cases inside and outside the window. 
Monte Carlo simulations are then used to generate random distributions of cases under the 
Poisson distribution, which are compared to the observed data to calculate a p-value. We set 
the maximum cluster size to 3 km, because spatial dependencies have previously been 
reported for HIV within this distance in this study area.21  
We also plotted the locations of clusters on a smoothed map of the relative proportion of 
DRTB patients compared to the underlying distribution in continuous geographical space. 
These maps were produced using kernel density estimation with a standard Gaussian kernel 
of 3km radius.  
Analyses were performed using R v 3.2.3, using the packages spatstat and rsatscan.22, 23 
 
RESULTS 
Between 2011 and 2015, there were 19,408 individuals admitted to Hlabisa hospital who 
could be allocated to a local area in the Hlabisa sub-district. Of these, 489 (2.5%) had an 
ICD-10 hospital discharge code indicating DRTB, among whom the majority (478, 98%) had 
MDR disease.  
Characteristics of patients with DRTB are shown in Table 1. Approximately half (250, 51%) 
the patients were female, and the modal age group was 25-34 years. There were 340 (70%) 
HIV positive DRTB patients, among whom 202 (60%) were on antiretroviral therapy at the 
time of admission. One in six (78, 16%) DRTB patients died prior to discharge, and five 
absconded from hospital.  
Local area analysis of DRTB in the Hlabisa sub-district 
We used the distribution of all 19,408 patients admitted to Hlabisa hospital across the local 
areas in the sub-district as a denominator for analyses of spatial clustering amongst the 489 
DRTB patients.  
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There was one high relative risk cluster, located in the south-east of the sub-district 
(p<0.001). This cluster had a radius of 1.9 km, comprised four local areas with a total of 79 
DRTB patients compared to 29 that would be expected by chance, and had a relative risk of 
3.0. There was some evidence of a low relative risk cluster in the west of the sub-district, 
close to the hospital (p=0.08). This cluster had a radius of 2.1 km; comprised four local areas 
with six patients compared to 19 expected, and a relative risk of 0.3. Locations of these two 
clusters, overlaid on a smoothed map of the relative proportion of DRTB patients compared 
to all hospital admissions are displayed in Figure 2. 
Micro-geographic analysis of DRTB in the AHRI demographic surveillance area 
There were 144 DRTB patients whose hospital data could be linked to the AHRI population 
surveillance data. Of these, 111 had a recorded homestead location during the study period 
and were included in the analysis (94 patients had a residential location recorded in the 
same year as their admission date; 16 of the remaining patients had a residence recorded 
before their admission date, and one had a residence location recorded the year after their 
admission date). The remaining 33 patients were excluded from this analysis because they 
did not have a homestead of residence recorded during the period of this study (2011-2015). 
The 111 patients with DRTB resided at 106 unique homestead locations; 10 patients shared 
homesteads with another patient. The most likely high relative risk cluster (p=0.057) had a 
radius of 2.8 km. The cluster comprised 55 patients compared to 31 that would be expected 
by chance, had a relative risk of 2.5, and all the homesteads with more than one patient 
were in this area. It was in a similar region to the high-risk cluster resulting from the local 
area-level analysis of the entire Hlabisa sub-district, in the south-east of the demographic 
surveillance area. This is the area around a township and is characterised by high population 
density and HIV prevalence compared to the rest of the demographic surveillance area.21 
There were no low relative risk clusters identified in this analysis.  
 
DISCUSSION 
In this study, we have described the spatial distribution of DRTB in the Hlabisa sub-district of 
KwaZulu-Natal for the first time. DRTB was highly prevalent in this region, with 489 (2.5%) of 
inpatients at Hlabisa hospital affected over a five-year period. Almost all had MDR disease 
and 16% died in hospital. There was clear evidence of a geographic high risk cluster of 
DRTB in the south-east of the region. This area is characterised by relatively high population 
density and high incidence and prevalence of HIV.21 This spatial heterogeneity of DRTB in a 
high burden, predominantly rural area was consistent with findings from lower HIV 
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prevalence settings, although our analysis was at a more granular level than most previous 
studies.6, 10, 11  
Establishing the spatial distribution of disease in rural areas such as the Hlabisa sub-district 
is challenging. This is because residential addresses are not recorded routinely in hospital 
systems, many people live in informal settlements which are not accurately mapped, and the 
population is highly mobile.24 A strength of our study is that we used precise residential 
locations collected in the AHRI demographic surveillance system. We were therefore able to 
derive the geographic distribution of DRTB from two different data sources: the self-reported 
local area of residence from hospital data, and, for residents of the AHRI demographic 
surveillance area, the homestead of residence. High risk clusters of disease were indicated 
in the same approximate area using both methods, suggesting that the observed clustering 
is genuine.  
The area of spatial clustering was characterised by high population density, and only 10 
(18%) patients in the cluster shared residences with other patients. This implies that 
transmission of DRTB in this community may have occurred in public places as well as 
within households. Other studies have also indicated the importance of community-based 
transmission of TB in similar settings.12, 25-30 Indoor venues with poor ventilation in which 
people come into close contact including healthcare facilities, public transport, churches and 
bars have been implicated as possible areas of transmission. An important component of 
DRTB prevention is therefore to identify such venues in the community and implement 
interventions including active case finding by regular screening; contact tracing; improving 
access to treatment, and airborne infection control measures in health facilities.  
The distinct spatial clustering of the disease suggests that targeting these interventions to 
suspected high transmission areas could be effective. However, our findings only reveal 
where people with DRTB reside, and uncovering precisely where transmission is occurring 
will require more detailed clinical and molecular epidemiology. A prospective cohort of 
people with DRTB is now operational in the study area where information is collected about 
social contact patterns and use of shared public spaces. This will be integrated with whole 
genome sequence data to provide better understanding of transmission. 
The results of our study also highlight the importance of the interaction between HIV and TB 
in this population. Almost three quarters of the patients with DRTB were HIV positive, 
compared to a prevalence in the population of approximately one quarter. The area of spatial 
clustering of DRTB was characterised by high HIV prevalence, and is in a similar region to a 
geographic cluster of HIV positive individuals identified previously.21 In this study population, 
approximately 60% of HIV positive patients were on antiretroviral therapy. Previous studies 
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have suggested that improved coverage of antiretroviral therapy at both the individual and 
community levels can contribute to reducing the incidence of TB.31-33 
Our study had several limitations. The analysis was restricted to DRTB patients, because we 
were only able to ascertain cases through hospital admissions data. Drug-sensitive TB 
patients are only admitted when clinically essential whereas policy at the time of the study 
was for all drug-resistant patients to be admitted for at least one month. We were therefore 
unable to determine whether the distribution of drug-resistant disease is similar to drug-
sensitive disease. Future studies in this area will integrate additional data from the electronic 
TB register (ETR.net) to characterise the distribution of drug-sensitive TB. 
The hospital information system used in this study also did not contain clinical information 
about history of treatment for TB. With the data available we therefore could not make any 
inference about the balance of primary and secondary drug resistance in the population. 
However, most recent data from high HIV prevalence settings suggest that, regardless of 
treatment history, the majority of DRTB cases arise from transmission.34  
Another limitation was the use of hospital discharge codes to define DRTB patients, which is 
an underestimate of the true number. We will have missed patients that were not coded in 
the hospital data as DRTB; children younger than 12 years who may have been managed 
elsewhere; individuals who had DRTB detected but did not go to hospital, and those with 
undetected disease. However, we have no reason to suspect that these factors would 
operate in a geographically heterogeneous way that would lead to spurious spatial clusters.  
The spatial analysis of DRTB in the wider Hlabisa sub-district was limited by use of local 
areas as opposed to individual addresses. However, results were similar to the analysis of 
precise point locations in the demographic surveillance area, which suggests that this 
method may be useful for similar analyses in future. We also used a hospital-based 
denominator as a proxy for the underlying population in this analysis. This will therefore be 
influenced by spatial factors which govern the distribution of conditions relating to other 
admissions. Finally, we described the characteristics of individuals using hospital data, but 
further information on patients would allow a more detailed analysis of risk factors in this 
population. 
CONCLUSIONS 
Our study shows concerning evidence of possible ongoing transmission of DRTB in this area 
of high prevalence. This suggests that targeting interventions to spatial areas of highest risk 
could be effective in supporting progress towards the WHO’s End TB strategy for a 90% 
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Table 1: Characteristics of drug-resistant tuberculosis patients, Hlabisa hospital (2011-2015) 























































Drug-resistant tuberculosis type 
 MDR 






















HIV/ ART status* 
 HIV positive, on ART 
 HIV positive, not on ART 
 HIV positive, ART missing 































MDR, multidrug-resistant; XDR, extensively drug-resistant; HIV, human immunodeficiency 
virus; ART, antiretroviral therapy. 























Figure 1: Study site 
A: Location of Hlabisa sub-district within South Africa 
B: Hlabisa sub-district, showing local areas and Africa Health Research Institute 
demographic surveillance area (shaded)  
C: Africa Health Research Institute demographic surveillance area, with roads and 





Figure 2: Spatial clustering of drug-resistant tuberculosis in Hlabisa sub-district, 2011-2015. 






Figure 3: Spatial clustering of drug-resistant tuberculosis in Africa Health Research Institute 
demographic surveillance area, 2011-2015. Locations determined by linking hospital data to 
individual homesteads in demographic surveillance system. 
 
